Skip to main content
Screener/Healthcare/Medical - Diagnostics & Research

MYGN — Myriad Genetics, Inc.

NASDAQ
$2.83-2.54 (-47.21%)
Small CapPenny StockUnder $5HealthcareHigh DividendDividend StockHigh Beta
$3.54
$8.59
$2.82
$3.26
EPS (TTM)$-4.30
P/E Ratio-1.23
Dividend Yield62.39%
Market Cap$529.9M
Volume10.47M
Prev Close$5.37
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$200.4M-$34.1M$-0.3668.7%-17.0%
Q4 '25$209.8M-$7.9M$-0.0870.0%-3.8%
Q3 '25$205.7M-$27.4M$-0.2969.9%-13.3%
Q2 '25$213.1M-$330.5M$-3.5771.2%-155.1%
Q1 '25$195.9M-$100K$-0.0068.5%-0.1%
Q4 '24$210.6M-$42.5M$-0.4771.7%-20.2%
Q3 '24$213.3M-$22.1M$-0.2470.2%-10.4%
Q2 '24$211.5M-$36.7M$-0.4169.6%-17.4%
Get Your Daily Market Recap